HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A C Bateman Selected Research

Cutaneous Malignant Melanoma

12/2005ICAM-1 polymorphisms and development of cutaneous malignant melanoma.
12/2003Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma.
6/2002Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma.
2/2002Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
2/2001Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism.
2/2001IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A C Bateman Research Topics

Disease

7Neoplasms (Cancer)
12/2021 - 02/2001
6Cutaneous Malignant Melanoma
12/2005 - 02/2001
3Necrosis
06/2005 - 02/2002
3Neoplasm Metastasis (Metastasis)
10/2002 - 02/2001
2Breast Neoplasms (Breast Cancer)
11/2010 - 08/2004
2Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
09/2005 - 11/2004
2Chronic Pancreatitis
06/2005 - 04/2002
2Carcinoma (Carcinomatosis)
04/2005 - 11/2004
2Adenocarcinoma
04/2005 - 02/2002
2Melanoma (Melanoma, Malignant)
02/2001 - 02/2001
1Lymphatic Metastasis
12/2021
1Extranodal Extension
12/2021
1Colorectal Neoplasms (Colorectal Cancer)
12/2021
1Fibrosis (Cirrhosis)
01/2021
1Non-alcoholic Fatty Liver Disease
01/2021
1Stomach Ulcer (Gastric Ulcer)
03/2005
1Gastritis
03/2005
1Margins of Excision
11/2004
1Skin Neoplasms (Skin Cancer)
06/2002
1talaromycosis
02/2002
1Infections
02/2002
1Basal Cell Carcinoma (Rodent Ulcer)
02/2002
1Squamous Cell Carcinoma of Head and Neck
12/2001
1Erectile Dysfunction
09/2000

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
06/2005 - 12/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2005 - 06/2002
2Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2005
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2005 - 06/2005
2Cell Adhesion MoleculesIBA
12/2005 - 06/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2005 - 02/2002
2Interleukin-8 (Interleukin 8)IBA
06/2005 - 08/2004
2Interleukin-6 (Interleukin 6)IBA
06/2005 - 08/2004
2Interleukin-10 (Interleukin 10)IBA
08/2004 - 02/2001
1tyramine-deoxysorbitolIBA
12/2021
1ErbB Receptors (EGF Receptor)IBA
11/2010
1Biological ProductsIBA
06/2009
1Actins (F Actin)IBA
09/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2005
1Interleukin-1beta (Interleukin 1 beta)IBA
06/2005
1Cell Adhesion Molecule-1IBA
06/2005
1Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2005
1Monoclonal AntibodiesIBA
03/2005
1myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA
11/2004
1InterleukinsIBA
08/2004
1Proteins (Proteins, Gene)FDA Link
10/2002
1Tissue Inhibitor of MetalloproteinasesIBA
04/2002
1Tissue Inhibitor of Metalloproteinase-2IBA
04/2002
1Retinoblastoma ProteinIBA
04/2002
1Fas Ligand Protein (Fas Ligand)IBA
04/2002
1Tissue Inhibitor of Metalloproteinase-1IBA
04/2002
1Cadherins (E-Cadherin)IBA
02/2002
1AntibodiesIBA
02/2002
1beta CateninIBA
02/2002
1oncofetal fibronectinIBA
12/2001
1Coloring Agents (Dyes)IBA
12/2001
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
02/2001
1GuanineIBA
02/2001
1Matrix Metalloproteinases (MMPs)IBA
02/2001

Therapy/Procedure

2Colectomy
04/2005 - 11/2004
1Neoadjuvant Therapy
12/2021
1Radiotherapy
04/2005
1Therapeutics
10/2002
1Sclerotherapy
09/2000